• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Evoke Pharma, Inc. (EVOK)

    -NasdaqCM
    6.32 Down 0.09(1.40%) Jun 24, 4:00PM EDT
    Prev Close:6.41
    Open:6.25
    Bid:2.38 x 500
    Ask:7.24 x 100
    1y Target Est:17.25
    Beta:N/A
    Earnings Date:Aug 11 - Aug 15 (Est.)
    Day's Range:5.24 - 6.88
    52wk Range:2.37 - 7.17
    Volume:131,044
    Avg Vol (3m):41,981
    Market Cap:45.76M
    P/E (ttm):N/A
    EPS (ttm):-1.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EVOK

    Comparison

    Symbol% ChgMkt Cap
    EVOKDown 1.40%45.76M
    SCMPDown 2.19%456.57M
    SLXP 0.00%10.88B
    OCRXUp 3.03%43.47M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.36
    Quarterly EPS Est (Jun-16) :-0.38
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback